AR and prostate cancer: In another study, Sjöstrom and colleagues (2022) saw that local 5hmC enrichment at enhancers or upstream of transcription start sites of prostate cancer drivers, most notably androgen receptor (AR) and forkhead box protein A1 (FOXA1), correlated with their gene expression [79].